Patent details

LUC00018 Product Name: acide obéticholique et ses dérivés pharmaceutiquement acceptables (OCALIVA)

Basic Information

Publication number:
LUC00018
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP027505262
Legal Status:
Active
Application number:
LUC00018
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/16/1139
Marketing Authorization Type:
Marketing Authorization Date:
15/12/2016
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
22/05/2017
First Marketing Authorization date:
15/12/2016
Grant date:
03/08/2017
Activation date:
21/02/2022
Publication date:
26/05/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
21/02/2027
SPC Extension Expiration:
21/02/2027
Rejection date:
Withdrawal date:

Owner

From:
22/05/2017
 
 

Name:
Intercept Pharmaceuticals, Inc.
Address:
10 Hudson Yards, 37th Fl., New York, NY 10001, United States (US)

Agent

Name:
Office FREYLINGER S.A.
From:
22/05/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2017/03
Publication date:
21/07/2017
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2017/05
Publication date:
13/09/2017
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
25
Annual Fee Amount:
450 Euro
Expected Payer:
Last Annual Fee Payment Date:
30/01/2025
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
440 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
22/05/2017 General Document 3
26/05/2017 Publication 1
22/05/2017 Application Form 4
26/05/2017 Outgoing Correspondence 1
22/05/2017 General Document 29
22/05/2017 General Document 2